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Abstract
Objective—To examine the predictive validity of the Modified Checklist for Autism in Toddlers 
(M-CHAT) administered at 24 months of age for autism spectrum disorder (ASD) diagnosed at 10 
years in a U.S. cohort of 827 Extremely Low Gestational Age Newborns (ELGAN) followed from 
birth.
Study design—We examined the sensitivity, specificity, positive predictive value and negative 
predictive value of the M-CHAT in predicting an ASD diagnosis at age 10 based on gold-standard 
diagnostic instruments. We then assessed how these predictive parameters were affected by 
sensorimotor and cognitive impairments, and socioeconomic status (SES), as well as emotional/
behavioral dysregulation at age 2.
Results—Using standard criteria, the M-CHAT had a sensitivity of 52%, a specificity of 84%, a 
positive predictive value (PPV) of 20%, and the negative predictive value (NPV) of 96%. False 
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positive and false negative rates were high among children who had hearing and vision 
impairments. High false positive rates were also associated with lower SES, motor and cognitive 
impairments, and emotional/behavioral dysregulation at age 2.
Conclusions—Among extremely preterm children with ASD, almost one-half were not 
correctly screened by the M-CHAT at age 2. Sensorimotor and cognitive impairments, SES, and 
emotional/behavioral dysregulation contributed significantly to M-CHAT misclassifications. 
Clinicians are advised to consider these factors when screening very preterm toddlers for ASD.
Keywords
Autism; M-CHAT; Screening; Preterm Children
The Modified Checklist for Autism in Toddlers (M-CHAT)1,2 is a widely-used screening 
instrument for autism spectrum disorder (ASD) for toddlers. M-CHAT consists of two 
phases: a parent-administered questionnaire and an inconsistently used follow-up interview 
with the parent.3 Because the most recent version of the M-CHAT (M-CHAT-Revised with 
Follow-Up) was validated in 2014, prior studies mainly used the M-CHAT as a questionnaire 
alone (as we do in this study), and resulted in high sensitivity and specificity (all above 
90%).4,5 In the absence of interview follow-up, positive predictive values (PPV) of the M-
CHAT have ranged from 0.14 to 0.64 in community-based samples.4,5
Although the prevalence of ASD is 1 to 2% in the general population,6,7 the prevalence in 
preterm children is several magnitudes higher (1.8 to 8%8–11). Sensory, motor, and cognitive 
impairments,11–13 as well as emotional/behavioral dysregulation,14 which can affect the 
validity of the M-CHAT, occur more often in very preterm toddlers than term children. 
Therefore, misclassification rates might be higher among preterm children with such 
deficits. A recent study has examined the validity of M-CHAT in preterm toddlers in relation 
to a concurrent ASD diagnosis made at age 2–413, but no studies of preterm toddlers have 
assessed how well the M-CHAT predicts the much more reliable, longer-term diagnosis of 
ASD in the preterm children at school age.
The purpose of this study was to examine the predictive validity of the M-CHAT 
administered at 24 months of age in relation to the diagnosis of ASD at school age in a 
cohort of Extremely Low Gestational Age Newborns (ELGAN) followed from birth. We 
evaluated overall M-CHAT predictive validity as well as the validity of each specific item 
with regard to ASD diagnosis. We also examined the extent to which developmental, 
demographic, behavioral and cognitive characteristics of extremely preterm children affected 
M-CHAT predictive validity.
METHODS
The ELGAN study is a multicenter prospective, observational study of the risk of structural 
and functional neurologic disorders in extremely preterm infants.15 A total of 1506 infants 
born before the 28th week of gestation were enrolled during the years 2002–2004 and 1200 
survived to 2 years. Analyses at age 24 months resulted in a report of overall rates of M-
CHAT positivity and the association of M-CHAT positivity with concurrent motor, 
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cognitive, visual and hearing impairments.12 Of the 1200 surviving children, 889 children 
were enrolled for the 10-year follow-up (Table I and Figure; Figure available at 
www.jpeds.com), when they were carefully evaluated for ASD. This enabled us to assess the 
predictive validity of the M-CHAT for ASD.
At approximately 24-months corrected age, children received a developmental assessment, 
which included a neurological examination, the Bayley Scales of Infant Development, 
second edition (BSID-II)16, and several parent reported assessments, including the M-CHAT 
and Child Behavior Checklist for Ages 1½ – 5 (CBCL)17 (Figure). The parent completed 
questionnaires regarding the child’s sensory and motor impairments. Nine hundred sixty-six 
families who participated in the 24-month evaluations were contacted by mail and then by 
phone to invite them to participate in the 10-year follow up. We searched for families who 
were lost to follow up using state vaccination registries, and other openly available websites. 
Facebook was also used where approved by the local institution’s Institutional Review 
Board. The enrollment and consent processes were approved by the Institutional Review 
Boards at each site.
M-CHAT
Primary caregivers completed the M-CHAT screener.12,13 The M-CHAT consists of 23 items 
for which the primary caregiver rates whether the child has or does not have the behavior 
specified.4 A child was considered to screen positive if 2 of 6 “critical” items (Table II) or 
three of any of the 23 total items were endorsed. A follow-up caregiver interview was not 
completed as part of the present investigation.
Gross motor function classification system (GMFCS)
Children’s motor function was assessed with the BSID-II Psychomotor Developmental 
Index (PDI) and the GMFCS at age 2 and 10.18 At age 2, a child was classified as GMFCS 
level 2 or higher if s/he could not sit, stand, or walk independently. A child who needed 
assistance to walk was classified as level 1, and a child who could walk was classified as 
level <1. At age 10, a child was classified as GMFCS level 5 if he or she had no self-
mobility. Because ASD cannot be validly diagnosed in children with severe motor 
impairments, children with no self-mobility at age 10 were excluded from diagnostic 
consideration of ASD.
Sensory impairments
Parents were asked to provide information about their child’s vision and hearing at age 2 and 
10. A child was considered to have visual impairment if the parent reported that the child 
was legally blind in at least one eye or if the child was receiving treatment or had surgery for 
lazy eye, strabismus, squint, or crossed eyes. A child was considered to have hearing 
impairments if the parent reported that the child used hearing aids, had a cochlear implant, 
or was receiving special services for the hearing impaired.12 As with children who had 
severe motor impairment, children with uncorrectable functional blindness in both eyes at 
age 10 were excluded from diagnostic assessment of ASD. No child had a hearing 
impairment of a severity that precluded a valid ASD assessment.
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Cognitive function
BSID-II Mental Development Index (MDI) was used to estimate the cognitive function at 
age 2.
Emotional/Behavioral dysregulation problems
The child’s primary caregiver chose one of three responses to each of the 99 characteristics 
listed in the CBCL/1½-5 at age 2: “not true,” “somewhat/sometimes true,” and “very true/
often true.16” Children were classified as having a significant dysregulation profile if the 
sum of the T scores for attention problems, aggressive behavior, and anxious/depressed 
subscales was ≥ 180.14
Autism assessment at age 10
All children were screened by parent report for risk of ASD with the Social Communication 
Questionnaire (SCQ).19 The SCQ includes 39 ratings for children with simple sentence 
speech and 33 ratings for those without simple sentence speech. To increase screener 
sensitivity, a score ≥ 11, recommended by the authors for individuals at higher-than-normal 
risk for ASD was used instead of the standard criterion of ≥ 15. Children determined at risk 
on the SCQ, were assessed with the Autism Diagnostic Interview–Revised (ADI-R), an in-
depth parent interview.20 Children meeting ADI-R modified criteria for ASD as suggested 
by the authors20,21 were administered the Autism Diagnostic Observation Schedule-2 
(ADOS-2).22 The only exceptions to this ASD assessment procedure were made for 9 
children who did not meet ADI-R criteria for ASD, but who were evaluated with the 
ADOS-2 because the child had a prior clinical diagnosis of ASD or the child was thought 
likely to meet ASD criteria based on the site psychologist’s clinical observation during 
cognitive testing of the child. For two additional children who met ADOS-2 diagnostic 
criteria for ASD, the ADI-R was not completed23.
Data analyses
We examined the sensitivity, specificity, PPV and NPV of the M-CHAT at the item and total 
score criteria level. The standard criteria for screening positive are “either 3 out of 23 total 
items OR 2 out of 6 critical items.” Due to a low sensitivity obtained from the standard 
criteria, we relaxed the cutoff scores to determine if a better balance between sensitivity and 
specificity could be achieved with more lenient criteria: (1) either 3 of 23 total items OR 1 of 
6 critical items; (2) either 2 of 23 total items OR 2 of 6 critical items; and (3) either 2 of 23 
total items OR 1 of 6 critical items.
We examined 24 month correlates by comparing the rates of motor, sensory, and cognitive 
impairments, emotional/behavioral dysregulation problems, and socioeconomic status 
among the correctly classified and misclassified cases in relation to the standard M-CHAT 
criteria.
RESULTS
Of 889 children in the sample, 26 children were excluded from an assessment of ASD at age 
10, 17 because of severe motor impairment and severe ID, 7 for functional blindness, and 2 
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for severe motor impairment, blindness, and ID combined. Of these 26 children, 19 did not 
achieve basal IQ scores. One child who met SCQ criteria and 5 children who met both SCQ 
and ADI-R criteria for ASD did not return to complete the ASD assessment, and were not 
included in the final sample. Of these 6 children, 4 did not achieve basal IQ scores, 1 scored 
in the mild ID range, and 1 family refused IQ testing. Of the 857 children who were 
evaluated for ASD at age 10, 827 had a completed M-CHAT of whom 58 met criteria for 
ASD (Figure).
Twenty percent 20% (n = 166) of the sample was born at 23–24 weeks, 45% (n = 370) at 
25–26 weeks of gestation, and 35% (n = 291) at 27 weeks of gestation. Thirty-six percent of 
the sample (n = 301) had a birth weight at or below 750 grams, 44% (n = 361) had a birth 
weight between 751 and 1000 grams, and 20% (n= 165) a birth weight more than 1000 
grams.
Children of mothers with black, Hispanic or other backgrounds were more likely to screen 
positive on the M-CHAT than children of white mothers (Table I). Children of single 
mothers and of mothers receiving public insurance were more likely to screen positive 
compared with children of married mothers and of mothers with HMO or private insurance. 
Male children were more likely to receive a diagnosis of ASD than female children. Lower 
birth weight was also associated with higher rates of screening positive on the M-CHAT and 
of ASD diagnosis.
Predictive validity of M-CHAT items
Sensitivities for the 6 critical items ranged from 10 to 43% (Table II). Sensitivities varied 
more for non-critical items, ranging from 0 to 43%. Specificities were notably higher for all 
items, ranging from 77 to 99%. PPVs ranged from 0 to 43%, but NPVs were higher, in the 
range of 93 to 96%.
Predictive validity of M-CHAT classification for ASD
When the standard criteria of the M-CHAT were used, 52% (sensitivity) of children who 
were later diagnosed with ASD were correctly identified at age 2 years, and 84% 
(specificity) of children without ASD were correctly excluded (Table III). Of the 153 
children who screened positive, only 20% (PPV) were subsequently diagnosed with ASD. 
Almost all children who screened negative (NPV of 96%) did not receive a diagnosis of 
ASD at age 10. Lower cutoffs on both total and critical item totals scores yielded more 
balanced sensitivities and specificities but lower PPVs.
We found moderate to strong associations between SES (ie, maternal education and public 
insurance status) and misclassification rates, specifically for false positives (Table IV). For 
instance, the false positive rate was highest for those whose parents received a 12th-grade or 
less education (21%), lower for those whose parents received 13–15th-grade education 
(15%), and the lowest for those whose parents received a 16th-grade or higher education 
(8%). Similarly, the false positive rate was higher for those who were eligible for public 
insurance (24%) than those who were not eligible (10%).
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The more severe a child’s motor impairments as assessed by the GMFCS and BSID-II 
Motor Scale (PDI), the more likely the child without ASD was to incorrectly screen positive 
(Table IV). For instance, the false positive rate was lowest in those who could walk (GMFCS 
< 1, 14%), intermediate in those needing assistance to walk (GMFCS = 1, 29%), and highest 
in those who could not sit or walk even with assistance (GMFCS ≥2, 48%). Moreover, the 
lower a child’s BSID-II PDI (another indicator of motor ability), the more likely the child 
without ASD was misclassified as having ASD (PDI < 55, 27%; PDI 56 to 69, 23%; PDI 
≥70, 11%). Similar to children without ASD, children with ASD were also more likely to 
screen positive as their motor impairments became more severe.
Vision and hearing impairments were associated with higher misclassification rates, both for 
false positives and false negatives (Table IV). For instance, the rate of false positives was 
higher in those with vision (38%) or hearing (41%) impairments compared with those 
without vision (15%) or hearing (14%) impairments, respectively. Similarly, the rate of false 
negatives was higher in those with vision (19%) or hearing (12%) impairments than in those 
without vision (3%) or hearing (3%) impairments, respectively.
The false positive rate was highest among children whose BSID-II MDI was below 55 
(32%), intermediate in those whose MDI was between 55 and 70 (28%), and lowest in those 
with an MDI 70 or higher (10%) (Table IV).
The rate of false positives was higher in those with (38%) than without (12%) the emotional/
behavioral dysregulation profile (Table IV).
DISCUSSION
This study evaluated the predictive validity of the M-CHAT at 2 years for the diagnosis of 
ASD at 10 years among children born extremely preterm. Of 58 children with ASD, about 
half screened positive on the M-CHAT (sensitivity = 52%). Of 153 children who screened 
positive, only 20% (PPV) were subsequently diagnosed with ASD. When predictive validity 
was examined at the item level, the prevalence of many behavioral features commonly 
considered early red flags for ASD varied widely among children later diagnosed with ASD, 
with sensitivities of individual items ranging from 0 to 43%. In contrast, 84% (specificity) of 
children without ASD did not screen positive on the M-CHAT. The item-level analyses also 
indicated that many of the behavioral features captured by the M-CHAT were highly specific 
to children with ASD.
Past studies using the M-CHAT have reported adequate sensitivities of the M-CHAT in the 
absence of follow-up interviews, ranging from 87 – 91%,2,3,5 although a recent study found 
lower sensitivity (ranging from 21 to 34% depending on criteria used) based on a general 
population sample.24 The results from our study suggest that various factors associated with 
extreme prematurity (such as sensory impairments) significantly affect the performance of 
the M-CHAT. In fact, in our sample, children with ASD were more likely to be missed by 
the M-CHAT when they had moderate vision or hearing impairments. PPV was also lower 
than expected in this sample; of 153 children who screened positive, only 20% were 
subsequently diagnosed with ASD, although it was comparable with the rate reported by a 
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past validation study of M-CHAT in the absence of follow-up interviews.5 In our study, false 
positive rates were also associated with sensory, motor, and cognitive impairments, SES, and 
emotional/behavioral dysregulation.
These results suggest that early detection of ASD in preterm infants may be influenced by 
various developmental and demographic factors. For instance, some sensory impairments 
observed in preterm infants may mask early symptoms of ASD, leading to false negatives, as 
reported here for a very small number of cases (n=2 for vision impairment only, n=3 hearing 
impairments only, n=1 for both vision and hearing impairments). Parents of children with 
sensory impairments and ASD may have overlooked the symptoms of ASD while attending 
to more disabling conditions that had persisted since infancy. It is also possible that because 
the sensory impairments identified for these 6 children at age 2 resolved by age 10, their 
sensory impairments as well as ASD symptoms might have been too mild to affect the skills 
rated with the M-CHAT. This finding underscores the importance of fostering recognition 
among parents and healthcare professionals that child characteristics, such as co-occurring 
vision and hearing impairments, may lead to underreporting of autism symptoms in children 
born extremely preterm. Conversely, some sensory and motor impairments may mimic early 
symptoms of ASD (e.g., difficulty with responding to name due to hearing impairments, 
difficulty with bringing objects to show parents due to limited mobility) resulting in false 
positives. False positive rates also were higher among families from lower socioeconomic 
backgrounds, consistent with past studies25. This finding might reflect the variability in 
parent’s expectation of what the child’s behavior should be, which may be affected by 
socioeconomic factors. Furthermore, factors such as sensorimotor or cognitive impairments 
that were found to affect the validity of the M-CHAT may be more prominent among 
children with lower socioeconomic backgrounds.27 In fact, we found higher severity or 
prevalence of sensory, motor and cognitive impairments as well as dysregulation profiles 
among children with lower socioeconomic background in our sample (Table V; available at 
www.jpeds.com).
Another possible explanation for the lower sensitivity of the M-CHAT is that some children 
may not show fully developed symptoms of ASD until 3 years of age. The M-CHAT can be 
administered validly to children as young as 18 months.4,5 However, up to 40% of children 
with ASD may not meet the full criteria to warrant a diagnosis of ASD at 18 month of age.28 
Similarly, in a recent general population study, only a third of toddlers who later developed 
ASD were correctly identified by the M-CHAT at 18 months of age.24 Many of these 
children, however, met the full criteria for ASD by age 3. It may be that a subset of ELGANs 
followed this later-onset trajectory, were missed by the M-CHAT at 24 months, and 
subsequently declined in their social communication abilities. The wide variability in 
sensitivities, ranging from 0 to 43% at the item level, may reflect this possibility given that 
almost half of preterm infants later diagnosed with ASD did not show early signs at 24 
months (e.g., lack of social smile, limited eye contact, diminished interest in social-
interactive play). These results point to the need for routine screening and continued 
developmental monitoring in order to enhance the early detection of ASD in preterm infants 
and to increase their access to early intervention.
Kim et al. Page 7
J Pediatr. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The predictive validity of the M-CHAT was evaluated in our sample based on ASD 
diagnoses made at age 10. Given that most past studies using the M-CHAT4,5 have not 
examined the longer-term predictive validity of the M-CHAT, our findings suggest that, for 
very pre-term cohorts, refinement of the screening items or use of more lenient criteria (i.e., 
lower cutoff scores) could improve the sensitivity of the measure for longer-term diagnostic 
outcomes. For instance, when we relaxed the M-CHAT standard criteria, we obtained more 
balanced sensitivity and specificity. However, more relaxed criteria may potentially lead to 
even lower PPV rates, although follow-up interviews have been recommended by the 
authors to decrease false positives and increase PPVs. Therefore, as screening measures are 
designed to maximize sensitivity while maintaining an adequate level of specificity, 
clinicians using the M-CHAT with very preterm children should consider further 
adjustments of the criteria accompanied by follow-up interviews. In addition, assessments 
for sensory, motor, and cognitive deficits as well as emotional/behavioral dysregulation, 
could improve the sensitivity of the M-CHAT for populations at heightened risk for ASD, 
including children born extremely preterm.
One of the strengths of our study is the long-term follow-up of extremely preterm infants, 
who were assessed for ASD at age 10 years, whereas past studies examining the predictive 
validity of the M-CHAT have considered concurrent or shorter term diagnostic outcomes. In 
addition, our results are based on a large sample of extremely preterm infants, selected on 
the basis of gestational age rather than birth weight. Our sample size allowed us to follow a 
substantial number of children with ASD prospectively and to examine characteristics of the 
family and child affecting the validity of the M-CHAT. A limitation of our study is that it did 
not include M-CHAT follow-up interviews, which may have decreased the PPV in the 
present study. However, follow-up interviews are recommended to further minimize false 
positives.
In a large study of children born extremely preterm, the specificity and negative predictive 
value of the M-CHAT were high but sensitivity and positive predictive value were lower than 
expected. This might, in part, reflect that demographic factors as well as cognitive, 
sensorimotor, and emotional/behavioral dysregulation problems appear to contribute to the 
misclassification rates of the M-CHAT. Clinicians using the M-CHAT for very preterm 
populations should consider using the standard criteria with caution, accompanied by 
follow-up interviews. Given the potential impact of these factors on misclassification rates, 
screening very preterm toddlers for ASD using the M-CHAT may need to be supplemented 
with other screening measures.
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M-CHAT Modified Checklist for Autism in Toddlers
ASD Autism Spectrum Disorder
ELGAN Extremely Low Gestational Age Newborn
SES Socioeconomic Status
PPV positive predictive value
NPV negative predictive value
GMFCS Gross Motor Functional Classification System
CBCL Child Behavior Checklist
ADOS Autism Diagnostic Observation Schedule
ADI -R, Autism Diagnostic Interview-Revise
SQC Social Communication Questionnaire
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School of Medicine, New Haven, CT: Richard Ehrenkranz, Jennifer Benjamin, Elaine 
Romano, Kathy Tsatsanis, Susan Dieterich, Karen Bearrs; Wake Forest University Baptist 
Medical Center, Winston-Salem NC: Nancy Peters, Patricia Brown, Emily Ansusinha, Ellen 
Waldrep, Jackie Friedman, Gail Hounshell, Debbie Allred; University Health Systems of 
Eastern Carolina, Greenville, NC: Stephen C. Engelke, Nancy Darden-Saad, Gary 
Stainback; North Carolina Children’s Hospital, Chapel Hill, NC: Diane Warner, Janice 
Wereszczak, Janice Bernhardt, Joni McKeeman, Echo Meyer; Helen DeVos Children’s 
Hospital, Grand Rapids, MI: Steve Pastyrnak, Wendy Burdo-Hartman, Julie Rathbun, Sarah 
Nota, Teri Crumb; Sparrow Hospital, Lansing, MI: Madeleine Lenski, Deborah Weiland, 
Megan Lloyd; University of Chicago Medical Center, Chicago, IL: Scott Hunter, Michael 
Msall, Rugile Ramoskaite, Suzanne Wiggins, Krissy Washington, Ryan Martin, Barbara 
Prendergast, Megan Scott; William Beaumont Hospital, Royal Oak, MI: Judith Klarr, Beth 
Kring, Jennifer DeRidder, Kelly Vogt.
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Figure; online only. 
Sample derivation. The sample (n=827) consists of the children who were evaluated for 
ASD at 10 years and with the M-CHAT at 2 years.
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Table 1
Characteristics of M-CHAT and children positive for ASD.
M-CHAT Positive ASD Positive Row N
Maternal Characteristics
Race White 15† 7 532
Black 24 8 202
Other 29 4 91
Hispanic Yes 28† 5 76
No 18 7 749
Maternal age < 21 19 5 102
21–35 20 7 553
> 35 14 8 172
Years of education ≤12 26† 8 342
13–15 17 4 185
≥16 11 7 300
Single Yes 24† 7 319
No 15 7 508
Public insurance Yes 28† 7 284
No 13 7 543
Perinatal characteristics
Any antenatal corticosteroids Yes 17† 7 731
No 26 7 95
Delivery complication PE/FI* 23 9 140
Spontaneous** 18 7 687
Newborn Characteristics
Sex Male 21 9† 421
Female 16 5 406
Gestational age, weeks 23–24 25 15† 166
25–26 17 6 370
27 16 3 291
Birth weight, grams ≤750 23† 11† 301
751–1000 17 4 361
> 1000 14 5 165
Maximum column N 153 58 827
Data are shown as row percentages except where noted (Row N and Maximum Column N).
*
Preeclampsia/Fetal indication
**
Preterm labor, preterm premature rupture of membranes, abruption, cervical insufficiency
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†
Indicates a significant association (p < 0.05) between the characteristic listed in the first column and M-CHAT positivity or ASD positivity, 
respectively.
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